عربي English Türkçe اردو فارسى
Logo
Latest News
Business

Kuwait KPC, Japan's Nippon Sign $1 Billion MoU to Enhance Economic Cooperation

An aerial view shows Kuwait city. Reuters
An aerial view shows Kuwait city. Reuters
TT
TT

Kuwait KPC, Japan's Nippon Sign $1 Billion MoU to Enhance Economic Cooperation

An aerial view shows Kuwait city. Reuters
An aerial view shows Kuwait city. Reuters

Kuwait Petroleum Corporation on Thursday signed a memorandum of understanding with the Japanese Nippon Export Investment Insurance (NEXI) to fund projects at a value estimated at one billion dollars.

KPC said in a statement that the MoU was inked to bolster bilateral relations between Kuwait and Japan and deepen economic and trade cooperation. It was co-signed by KPC Chief Executive Officer Sheikh Nawaf Saud Al-Sabah and a senior executive of the Japanese company.

Attending the signing ceremony were Deputy Prime Minister, Minister of Oil and Minister of State for Cabinet Affairs and KPC Chairman, Dr. Mohammad Al-Fares, and Japanese Minister of Economy and Commerce Hagiuda Koichi.

The Japanese firm will cooperate with KPC to find investment opportunities for Japanese companies in Kuwait and contribute to initiatives designed to cut carbon emissions. Moreover, it aims to promote Japanese products in Kuwait and provide credit facilities for projects executed by the KPC and its affiliates.

Most Viewed

 
 
Business

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.